MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

48 results · 1 filter active ·
Results by year
20142025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
48 works in the cohort · of 4,299,418page 1 of 1

Labels cover 0 of 48 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 48 of 48 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundunlabeled
Antioxidants and Chronic Obstructive Pulmonary Disease
Felix-Antoine Vézina, André M. Cantin
2018· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
33
citations
affunlabeled
Nutrition and Markers of Disease Severity in Patients With Bronchiectasis
Katherine A. Despotes, Radmila Choate, Doreen Addrizzo‐Harris, Timothy R. Aksamit, Alan R. Barker, Ashwin Basavaraj +18 more
2020· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
17
citations
affaboutunlabeled
Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study
Robert A. Wise, Kenneth R. Chapman, Benjamin M. Scirica, David Schoenfeld, Deepak L. Bhatt, Sami Z. Daoud +3 more
2017· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
9
citations
affunlabeled
The COPD Foundation Pocket Consultant Guide
Byron Thomashow, James D. Crapo, Barbara P. Yawn, Andrew McIvor, Scott Cerreta, John Walsh +2 more
2014· review· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Intraindividual Variability in Serum Alpha-1 Antitrypsin Levels
Annie Haillot, Andrée-Anne Pelland, Yohan Bossé, Tomás P. Carroll, François Maltais, Ronald J. Dandurand
2021· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
fundno affunlabeled
The COPD Pipeline XXXVI
Nicholas J. Gross
2017· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
1
citations
fundno affunlabeled
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions
Arnaud Bourdin, Gerard J. Criner, Gilles Devouassoux, Mark T. Dransfield, David Halpin, MeiLan K. Han +17 more
2020· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Editorial: Risk Prediction in Smokers
Jørgen Vestbo
2020· editorial· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
The COPD Foundation on Its Twentieth Anniversary
Elisha Malanga, Byron Thomashow, Jean Ann Wright, Linda Walsh, Cathy Gray Carlomagno, Jamie Sullivan +11 more
2024· article· en· Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About